A detailed history of Ntb Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ntb Financial Corp holds 43,396 shares of BMY stock, worth $2.49 Million. This represents 2.71% of its overall portfolio holdings.

Number of Shares
43,396
Previous 43,551 0.36%
Holding current value
$2.49 Million
Previous $3.18 Million 5.03%
% of portfolio
2.71%
Previous 2.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $11,256 - $12,396
-155 Reduced 0.36%
43,396 $3.34 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $2,951 - $3,538
-48 Reduced 0.11%
43,551 $3.18 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $2.34 Million - $2.73 Million
43,599 New
43,599 $2.72 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ntb Financial Corp Portfolio

Follow Ntb Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntb Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ntb Financial Corp with notifications on news.